← FDA Drug Approvals (Drugs@FDA)

FUROSEMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT · Approved 2021-01-27

Drug application

FDA Application #
ANDA214766
Application type
Abbreviated New Drug Application (Generic)
Brand name
FUROSEMIDE
Generic name
FUROSEMIDE
Active ingredients
FUROSEMIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
SAGENT
Manufacturer
Sagent Pharmaceuticals
First approval
2021-01-27

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown